panitumumab   Click here for help

GtoPdb Ligand ID: 6883

Synonyms: ABX-EGF | ABX-EGF Mab | Vectibix®
Approved drug
panitumumab is an approved drug (FDA (2006), EMA (2007))
Compound class: Antibody
Comment: Binds to and competitively inhibits the activity of the epidermal growth factor receptor.
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
Classification Click here for help
Compound class Antibody
Approved drug? Yes (FDA (2006), EMA (2007))
International Nonproprietary Names Click here for help
INN number INN
8499 panitumumab
Synonyms Click here for help
ABX-EGF | ABX-EGF Mab | Vectibix®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 196
Other databases
GtoPdb PubChem SID 178103465
PubChem SID 178103465
Search PubMed clinical trials panitumumab
Search PubMed titles panitumumab
Search PubMed titles/abstracts panitumumab
Wikipedia Panitumumab